U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C29H33ClFNO4
Molecular Weight 514.028
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ENCALERET

SMILES

C[C@@H](OC[C@H](O)CNC(C)(C)CC1=CC(F)=C(Cl)C=C1)C2=C(C=CC=C2)C3=CC=C(C(O)=O)C(C)=C3

InChI

InChIKey=UNFHDRVFEQPUEL-DENIHFKCSA-N
InChI=1S/C29H33ClFNO4/c1-18-13-21(10-11-23(18)28(34)35)25-8-6-5-7-24(25)19(2)36-17-22(33)16-32-29(3,4)15-20-9-12-26(30)27(31)14-20/h5-14,19,22,32-33H,15-17H2,1-4H3,(H,34,35)/t19-,22-/m1/s1

HIDE SMILES / InChI

Molecular Formula C29H33ClFNO4
Molecular Weight 514.028
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Encaleret (JTT-305 or MK-5442) is a potent oral short-acting calcium-sensing receptor (CaSR) antagonist and transiently stimulates endogenous parathyroid hormone (PTH) secretion. CaSR antagonists stimulate endogenous PTH secretion through CaSR on the surface of parathyroid cells and thereby may be anabolic agents for osteoporosis. Japan Tobacco and Merck were developing encaleret for the treatment of osteoporosis however development has been discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
[Antagonist for calcium-sensing receptor. JTT-305/MK-5442].
2011 Jan
Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.
2012 Jun
A semimechanistic model of the time-course of release of PTH into plasma following administration of the calcilytic JTT-305/MK-5442 in humans.
2013 Aug
Patents

Patents

Sample Use Guides

Phase II studies: 2.5 - 15 mg daily
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:14:36 GMT 2023
Edited
by admin
on Fri Dec 15 19:14:36 GMT 2023
Record UNII
EF8081AQ6G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ENCALERET
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
Encaleret [WHO-DD]
Common Name English
2'-((1R)-1-(((1-(4-CHLORO-3-FLUOROPHENYL)-2-METHYLPROPAN-2-YL)AMINO)-(2R)-2-HYDROXYPROPOXY)ETHYL)-3-METHYL(1,1'-BIPHENYL)-4-CARBOXYLIC ACID
Systematic Name English
2'-((1R)-1-((2R)-3-((1-(4-CHLORO-3-FLUOROPHENYL)-2-METHYLPROPAN-2-YL)AMINO)-2-HYDROXYPROPOXY)ETHYL)-3-METHYL(1,1'-BIPHENYL)-4-CARBOXYLIC ACID
Systematic Name English
encaleret [INN]
Common Name English
(1,1'-BIPHENYL)-4-CARBOXYLIC ACID, 2'-((1R)-1-((2R)-3-((2-(4-CHLORO-3-FLUOROPHENYL)-1,1-DIMETHYLETHYL)AMINO)-2-HYDROXYPROPOXY)ETHYL)-3-METHYL-
Common Name English
2'-((1R)-1-(((2R)-3-((1-(4-CHLORO-3-FLUOROPHENYL)-2-METHYLPROPAN-2-YL)AMINO)-2-HYDROXYPROPYL)OXY)ETHYL)-3-METHYL-1,1'-BIPHENYL-4-CARBOXYLIC ACID
Systematic Name English
ENCALERET [USAN]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C169946
Created by admin on Fri Dec 15 19:14:36 GMT 2023 , Edited by admin on Fri Dec 15 19:14:36 GMT 2023
PRIMARY
INN
9473
Created by admin on Fri Dec 15 19:14:36 GMT 2023 , Edited by admin on Fri Dec 15 19:14:36 GMT 2023
PRIMARY
SMS_ID
100000175069
Created by admin on Fri Dec 15 19:14:36 GMT 2023 , Edited by admin on Fri Dec 15 19:14:36 GMT 2023
PRIMARY
CAS
787583-71-5
Created by admin on Fri Dec 15 19:14:36 GMT 2023 , Edited by admin on Fri Dec 15 19:14:36 GMT 2023
PRIMARY
PUBCHEM
46917559
Created by admin on Fri Dec 15 19:14:36 GMT 2023 , Edited by admin on Fri Dec 15 19:14:36 GMT 2023
PRIMARY
FDA UNII
EF8081AQ6G
Created by admin on Fri Dec 15 19:14:36 GMT 2023 , Edited by admin on Fri Dec 15 19:14:36 GMT 2023
PRIMARY
ChEMBL
CHEMBL1672973
Created by admin on Fri Dec 15 19:14:36 GMT 2023 , Edited by admin on Fri Dec 15 19:14:36 GMT 2023
PRIMARY
USAN
XX-158
Created by admin on Fri Dec 15 19:14:36 GMT 2023 , Edited by admin on Fri Dec 15 19:14:36 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY